Lonza Group Ltd. Provisionally Allotted 30 Acres Of Land In The “Genome Valley”, Hyderabad (India)

Basel, 29 May 2009 – Lonza Group Ltd announces that it is in negotiations with the Andhra Pradesh Industrial Infrastructure Corporation Ltd, a government agency located in Hyderabad, India, about the acquisition or lease of land in the “Genome Valley” for the establishment of R&D and manufacturing facilities. Whilst Lonza has been provisionally allotted 30 Acres of land and is currently negotiating the terms and conditions of an agreement. The outcome of the negotiations remains open.

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cellbased research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2008, Lonza had sales of CHF 2.937 billion. Further information can be found at www.lonza.com.

MORE ON THIS TOPIC